IGCAN Directory
login/create account
DonateNew Online Education Offerings
Phase II PICCOLO
Trial Results
Cervical Cancer Survivorship: A Patient's Perspective
Using Ultrasound in Image-Guided Brachytherapy: Everything Old is New Again
Home > Educational Webinars
Recently Recorded
Education360 Journal Club
Held Live February 25
Article - Surgical versus clinical staging prior to primary chemoradiation in patients with cervical cancer FIGO stages IIB–IVA: oncologic results of a prospective randomized international multicenter (Uterus-11) intergroup study
Author: Audrey Tsunoda, MD
Personalized Management of Advanced or Recurrent Endometrial Cancers: Navigating pMMR, dMMR Subtypes, or Molecular Classifications
IGCS and Eisai welcomes you to view Personalized Management of Advanced or Recurrent Endometrial Cancers: Navigating pMMR, dMMR Subtypes, or Molecular Classifications Industry Supported Symposium presented at the IGCS 2024 Annual Global Meeting in Dublin, Ireland. This course offers an in-depth exploration of personalized treatment approaches for endometrial cancers, focusing on proficient mismatch repair (pMMR), deficient mismatch repair (dMMR) diseases and molecular classification in the recurrent setting. Through case-based studies, and analysis of clinical data, participants will gain insights into tailored treatment strategies, including the use of immune checkpoint inhibitors, chemotherapy, and targeted therapies. The course also examines the challenges of managing treatment toxicities and poor tolerance in pMMR patients, utilizing evidence from post-adjuvant sub-analyses to inform decision making and optimize patient outcomes.
pMMR vs dMMR Disease, Molecular Considerations in the Recurrent and First Line Setting
John Chan, MD,
California Pacific Medical Center, Sutter Health,
USA
Part 1 Released February 2025
Eisai have sponsored this initiative with IGCS and had no input into or influence over the content.
Immunotherapy Toxicities Nursing Tumor Board
IGCS nursing workgroup held their first tumor board and discussed nursing care options for a cervical cancer patient experiencing immunotherapy toxicities. The next tumor board will be planned for March.
Case presentation by Sarah Belton, RN (Ireland)
Moderated by Anne Mellon, RN (Australia) and Chrissy Donovan, RN (USA)
Journal Club: Tisotumab Vedotin as Second- or Third-Line
Therapy for Recurrent Cervical Cancer
Listen to a new Journal Club with PI Dr. Brian Slomovitz and moderator Dr. Leslie Randall as they discuss details on the New England Journal of Medicine published article Tisotumab Vedotin as Second- or Third-Line Therapy for Recurrent Cervical Cancer.
Brian Slomovitz, MD
Leslie Randall, MD
Multidisciplinary Conversations with Radiation Oncologist Carien Creutzberg
IGCS Education360 Radiation Oncology Workgroup, chaired by Dr. Pearly Khaw, interview with Professor Carien Creutzberg, recipient of the IGCS 2024 Lifetime Achievement Award. She discusses her pioneering work and the significance of international collaboration. Creutzberg reflects on the evolution of research questions in clinical trials, the integration of molecular and immunotherapy advancements, and the importance of multidisciplinary teams in enhancing patient care and treatment outcomes.
Carien Creutzberg, MD, PhD
Symptom Triggered Testing for Ovarian Cancer
Ovarian cancer symptoms are often vague and non-specific, leading to delayed diagnoses. Prof. Sudha Sundar discusses symptom-triggered testing in ovarian cancer detection, including ROCkeTS, which support that early diagnosis through symptom-triggered testing which could lead to improved diagnosis of early-stage high grade serous ovarian cancer and low-volume disease.
Professor Sudha Sundar
Professor of Gynaecological Cancer
University of Birmingham
Lead National Ovarian Cancer Audit
United Kingdom
Phase II PICCOLO Trial Results
Angeles Alvarez Secord, MD, MHSc
Professor of Obstetrics and Gynecology
Duke University School of Medicine
USA
Wendel Naumann, MD
Director of Minimally Invasive Surgery in Gynecologic Oncology
Carolinas Medical Center Associate Medical Director of Clinical Trials
Associate Medical Director of Clinical Trials
Levine Cancer Institute, Atrium Health
USA
Using Ultrasound in Image-Guided Brachytherapy:
Everything Old is New Again
Dr. Sylvia van Dyk, PhD
Peter MacCallum Cancer Institute
Australia
Dr. Kelvin Ken Yu
University of Santo Tomas Hospital
Manila, Philippines
Dr. Ryan Urban, FRCPC
BC Cancer
Canada
Dr. Onyinye Balogun
Weill Cornell Medicine
United States
Moderated by Dr. Pearly Khaw, Australia.
Gynecologic Brachytherapy: Fundamentals of Nursing Care
Kayla Kafka-Peterson, RN, BSN
Nursing Supervisor II Radiation Oncology
Brachytherapy Program Operations Oversight
University of California Los Angeles (UCLA)
USA
Puja Venkat, MD
Assistant Clinical Professor, Radiation Oncology
Equity, Diversity and Inclusion Co-Chair
University of California Los Angeles (UCLA)
USA
View previous webinar, Radiation Treatment for Gynecologic Malignancies and the Vital Role of Nursing.
Cervical Cancer Survivorship: A Patient's Perspective
In this IGCS Advances & Updates special presentation, Heidi Burgard, a cervical cancer survivor shares her story and experience with clinical trials. Heidi is joined by her gynecologic oncologist, Dr. Saketh Guntupalli, Professor and Director of the Division of Gynecologic Oncology at the University of Colorado School of Medicine at Denver.
Heidi Burgard
Cervical Cancer Survivor & Advocate
Saketh Guntupalli, MD
University of Colorado School
of Medicine at Denver
Uterine mesenchymal neoplasms: new and evolving entities
In this session, we will review new and evolving uterine mesenchymal entities as well as biomarker and molecular assays to aid in these diagnoses. Additionally, appropriate diagnostic terminology will be covered in the absence of accessible immunohistochemistry and molecular testing.
This webinar is complimentary for IGCS members.
Brooke Howitt, MD
Associate Professor of Pathology
Stanford University School of Medicine
USA
Adrian Suarez, MD
Moderator
Surgical Pathology Director
The Ohio State University Wexner Medical Center
USA
Palliative Care in Disaster and Conflict Settings
Political and ethnic conflict, and geological and climatic disasters, result in suffering on a massive scale, particularly in low- and middle-income countries with fragile health care systems. Palliative care, defined most often as a response to physical, psychological, social, or spiritual suffering of those with “life-limiting illness,” is crucial for those with such illnesses in humanitarian settings. But those without life-limiting illnesses also suffer severely, due, for example, to gender-based violence or to witnessing and fleeing from extreme violence. This webinar will explore how, in humanitarian settings, palliative care can and should be true to its mission of responding to suffering without the constraint of focusing only on those with life-limiting illnesses.
This webinar is complimentary for IGCS members.
Eric L. Krakauer, MD, PhD
Director, Program in Global Palliative Care
Associate Professor of Medicine
Associate Professor of Global Health & Social Medicine
Harvard Medical School
USA
Annekathryn “AK” Goodman, MD, MS, MPH
Professor of Obstetrics, Gynecology and Reproductive Biology
Harvard Medical School
USA
Nahla Gafer, MD
Clinical Oncologist & Head Palliative Care Unit
Khartoum Oncology Hospital
Director, Palliative Care Continuous Education
Comboni College of Science and Technology
Sudan
Peter Grant, MD
Moderator
Assoc Professor, University of Melbourne
Gynaecological Oncologist, Western Health, Melbourne
Australia
Anisa Mburu, MD
Moderator
Gynecologic Oncologist
Aga Khan Hospital and International Cancer Institute
Kenya
Cervical Cancer Survivorship:
A Patient's Perspective
In this IGCS Advances & Updates special presentation, Linda Ryan, a metastatic recurrent cervical cancer survivor and patient research advocate shares her story and experience with clinical trials. Linda is joined by her gynecologic oncologist, Dr. Shannon Westin, a professor of gynecologic oncology at the University of Texas MD Anderson Cancer Center in Houston, Texas. Listen to Linda and Dr. Westin as they discuss recent approval and therapeutic options for patients with recurrent cervical cancer.
Emerging Data in platinum resistance advanced ovarian cancer
Lainie P. Martin, MD
Leader, Gynecology/Oncology Program
Associate Professor of Medicine (Hematology-Oncology) at the Hospital of the University of Pennsylvania
Associate Professor of Obstetrics and Gynecology
University of Pennsylvania Perelman School of Medicine
USA
David O’Malley, MD
Ohio State University Comprehensive Cancer Center-James Cancer Hospital &
Solove Research Institute Professor
Director, Division of Gynecologic Oncology
Co-Director, Gyn Oncology Phase I Program
USA
Selinexor in Maintenance Therapy After Systemic Therapy for Patients with p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma: XPORT-042 - Trial in Progress
Robert Coleman, MD, FACOG, FACS
Chief Medical Officer
Vaniam Group
USA
Floor Backes, MD
Moderator
Director of Clincial Research and Fellowship Director for the Division of Gynecologic Oncology
The Ohio State University Wexner Medical Center
James Comprehensive Cancer Center
USA
Available as a Podcast!
Would you rather listen to this recording? Listen on Education360 Learning Portal or the streaming services below!
